Andexxa lawsuit attorneys cornell & greene

Andexxa

Investigating Serious Complications Linked to Anticoagulant Reversal Drug

Contact Us
andexxa lawsuit case for cornell and greene in texas

When a patient experiences life-threatening bleeding while on a blood thinner, emergency intervention is critical.

Andexxa was developed as a reversal agent for certain Factor Xa inhibitor anticoagulants. It is intended to rapidly reverse the blood-thinning effects of medications such as Eliquis and Xarelto in emergency situations.

However, serious safety concerns have been raised regarding Andexxa’s risks, including blood clots, stroke, heart attack, and sudden death.

What Is the Basis of the Lawsuits?

Pharmaceutical companies have a legal duty to:

  • Conduct thorough clinical testing

  • Accurately report safety data

  • Provide clear and adequate warnings

  • Update risk information as new data emerges

Lawsuits involving Andexxa may allege:

  • Failure to adequately warn about thrombotic risks

  • Misrepresentation of safety profile

  • Insufficient post-market safety monitoring

  • Aggressive marketing despite known complications

When incomplete risk information affects emergency medical decisions, the consequences can be catastrophic.

Serious complications associated with Andexxa may include:

  • Stroke

  • Heart attack

  • Deep vein thrombosis (DVT)

  • Pulmonary embolism

  • Systemic blood clots

  • Cardiac arrest

  • Death

Some reports indicate that thrombotic events occurred within days or weeks after administration.

Families allege they were not fully informed of the potential dangers before the drug was used.

Alleged Risks and Complications

  • Andexxa (andexanet alfa) is administered intravenously in hospital settings to reverse the effects of certain anticoagulant medications during uncontrolled or life-threatening bleeding.

    Because it rapidly restores clotting ability, it also carries an inherent risk: excessive clot formation.

    Plaintiffs allege that the manufacturer failed to fully disclose or adequately emphasize the heightened risk of thrombotic events following administration.

  • Andexxa is used to reverse the effects of certain Factor Xa inhibitor blood thinners, such as Eliquis and Xarelto, during life-threatening bleeding emergencies.

  • Because Andexxa restores the blood’s ability to clot, it may increase the risk of excessive clot formation. In some patients, this can lead to stroke, heart attack, or other thrombotic events.

  • Reports indicate that clotting events may occur within days or weeks after administration. Timing is an important factor in evaluating a potential claim.

  • Yes. If a loved one passed away following complications linked to Andexxa, surviving family members may have grounds to pursue a wrongful death claim, depending on state law.

  • You may qualify for an Andexxa lawsuit if:

    • You or a loved one received Andexxa in a hospital setting

    • A stroke, heart attack, clotting event, or other serious complication followed

    • The complication occurred shortly after administration

    • The injury resulted in permanent damage or death

    Wrongful death claims may also be available for families who lost a loved one following Andexxa treatment.

    Each case requires careful medical record review and expert analysis.

  • We prepare every case as if it will go before a jury. Large corporations know the difference between a firm that settles quickly and a firm that is prepared to litigate aggressively.

    We offer:

    • Free case evaluations

    • No fees unless we recover compensation

    • Direct communication with your legal team

    • Strategic, evidence-driven litigation

    If you have been harmed, we will pursue the accountability you deserve.

Contact Us Today

If you or a loved one suffered a stroke, heart attack, clotting event, or other serious complication after receiving Andexxa, contact us for a free and confidential consultation.

See why Cornell & Greene, PLLC is unlike any other law firm.